MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 128 filers reported holding MACROGENICS INC in Q3 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $37,741 | -20.7% | 8,099 | -8.9% | 0.00% | – |
Q2 2023 | $47,572 | +15.4% | 8,892 | +54.7% | 0.00% | – |
Q1 2023 | $41,213 | +6.9% | 5,748 | 0.0% | 0.00% | – |
Q4 2022 | $38,569 | -35.7% | 5,748 | -66.5% | 0.00% | – |
Q3 2022 | $60,000 | +20.0% | 17,161 | +0.8% | 0.00% | – |
Q2 2022 | $50,000 | -73.3% | 17,032 | -19.7% | 0.00% | – |
Q1 2022 | $187,000 | -45.0% | 21,212 | -0.1% | 0.00% | – |
Q4 2021 | $340,000 | -20.7% | 21,225 | +3.7% | 0.00% | – |
Q3 2021 | $429,000 | +43.0% | 20,469 | +83.2% | 0.00% | – |
Q2 2021 | $300,000 | -2.3% | 11,173 | +16.0% | 0.00% | – |
Q1 2021 | $307,000 | +42.8% | 9,632 | +2.5% | 0.00% | – |
Q4 2020 | $215,000 | -8.1% | 9,398 | +1.5% | 0.00% | – |
Q3 2020 | $234,000 | -23.0% | 9,256 | -14.8% | 0.00% | – |
Q2 2020 | $304,000 | +406.7% | 10,866 | +5.3% | 0.00% | – |
Q1 2020 | $60,000 | -54.2% | 10,318 | -14.0% | 0.00% | – |
Q4 2019 | $131,000 | -7.1% | 11,996 | +7.9% | 0.00% | – |
Q3 2019 | $141,000 | -8.4% | 11,122 | +22.8% | 0.00% | – |
Q2 2019 | $154,000 | +14.9% | 9,059 | +21.9% | 0.00% | – |
Q1 2019 | $134,000 | +42.6% | 7,432 | 0.0% | 0.00% | – |
Q4 2018 | $94,000 | -28.8% | 7,432 | +20.4% | 0.00% | – |
Q3 2018 | $132,000 | +3.1% | 6,171 | 0.0% | 0.00% | – |
Q2 2018 | $128,000 | -21.5% | 6,171 | -4.8% | 0.00% | – |
Q1 2018 | $163,000 | -4.7% | 6,482 | -27.9% | 0.00% | – |
Q4 2017 | $171,000 | +6.2% | 8,986 | +2.8% | 0.00% | – |
Q3 2017 | $161,000 | +16.7% | 8,739 | +10.3% | 0.00% | – |
Q2 2017 | $138,000 | 0.0% | 7,925 | +4.3% | 0.00% | – |
Q1 2017 | $138,000 | -11.5% | 7,597 | -1.5% | 0.00% | – |
Q4 2016 | $156,000 | +14.7% | 7,713 | +68.0% | 0.00% | – |
Q3 2016 | $136,000 | +3.0% | 4,592 | -6.1% | 0.00% | – |
Q2 2016 | $132,000 | +48.3% | 4,892 | 0.0% | 0.00% | – |
Q1 2016 | $89,000 | -26.4% | 4,892 | +25.1% | 0.00% | – |
Q4 2015 | $121,000 | +47.6% | 3,909 | 0.0% | 0.00% | – |
Q3 2015 | $82,000 | -42.3% | 3,909 | 0.0% | 0.00% | – |
Q2 2015 | $142,000 | +13.6% | 3,909 | 0.0% | 0.00% | – |
Q1 2015 | $125,000 | -8.8% | 3,909 | 0.0% | 0.00% | – |
Q4 2014 | $137,000 | +73.4% | 3,909 | 0.0% | 0.00% | – |
Q3 2014 | $79,000 | – | 3,909 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 2,115,000 | $37,034,000 | 8.81% |
INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $18,811,000 | 4.45% |
DAFNA Capital Management LLC | 119,200 | $2,087,000 | 1.49% |
BB BIOTECH AG | 2,350,112 | $41,150,000 | 1.26% |
TIGER MANAGEMENT L.L.C. | 239,667 | $4,197,000 | 0.82% |
Hood River Capital Management LLC | 576,193 | $10,089,000 | 0.70% |
Bellevue Group AG | 316,418 | $5,540,000 | 0.66% |
Rhenman & Partners Asset Management AB | 175,000 | $3,064,000 | 0.44% |
First Light Asset Management, LLC | 61,538 | $1,078,000 | 0.36% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 54,000 | $945,000 | 0.36% |